Dr. Aponte successfully defended her PhD thesis, “Post-translational Regulation of the RB Tumor Suppressor in Response to CDK4/6 Inhibition” under the mentorship of Dr. Mike Emanuele!
Publications
Charting the multilevel molecular response to palbociclib in ER-positive breast cancer.Kavalipati A, Aponte A, Sullivan ME, Whittington SL, Martínez JC, Goda GA, Aleman MM, Emanuele MJ, Dominguez D.NAR Cancer. 2026 Feb 17;8(1):zcag003. doi: 10.1093/narcan/zcag003. eCollection 2026 Mar. PMID: 41710088. PMC12910112.
Characterizing the Impact of the Cell Cycle on mRNA Lipid Nanoparticles. VanKeulen-Miller R, Aponte A, Tiwade PB, Narasipura EA, Fung V, Andersen S, Gill NA, Emanuele M, Fenton OS.J Am Chem Soc. 2026 Jan 21;148(2):2779-2791. doi: 10.1021/jacs.5c20083. Epub 2026 Jan 8. PMID: 41502411.
Honors, Awards & Highlights
NIH/NCI F31 Fellowship
Burroughs Wellcome Fund Award
Dr. Aponte is currently a medical writer for Phoenix Rising Communications.
We wish you all the best, Amy!